Untangling therapeutic ingredients of a personalized intervention for patients with depression and severe copd

American Journal of Geriatric Psychiatry

Volumn 22, Issue 11, 2014, Pages 1316-1324

  Alexopoulos, George S ^a   Kiosses, Dimitris N ^a   Sirey, Jo Anne ^a   Kanellopoulos, Dora ^a   Seirup, Joanna K ^a   Novitch, Richard S ^b   Ghosh, Samiran ^a   Banerjee, Samprit ^a   Raue, Patrick J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b BURKE REHABILITATION HOSPITAL   (United States)

Author keywords

Clinical trial; COPD; disability; dyspnea; geriatric depression; personalized intervention

Indexed keywords

AMFEBUTAMONE; CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; MIRTAZAPINE; NORTRIPTYLINE; PAROXETINE; SERTRALINE; VENLAFAXINE; ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; ASSESSMENT OF HUMANS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY; CONTROLLED STUDY; DISABILITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPNEA; EXERCISE; FEMALE; FUNCTIONAL STATUS; HAMILTON DEPRESSION RATING SCALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICATION COMPLIANCE; MENTAL PATIENT; PATIENT COMPLIANCE; PERSONALIZED INTERVENTION FOR DEPRESSED PATIENTS WITH COPD; PERSONALIZED MEDICINE; PULMONARY FUNCTIONAL STATUS AND DYSPNEA QUESTIONNAIRE MODIFIED; PULMONARY REHABILITATION; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SCREENING TEST; TREATMENT DURATION; TREATMENT OUTCOME; COMPLICATION; DEPRESSIVE DISORDER, MAJOR; LUNG FUNCTION TEST; MIDDLE AGED; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; INDIVIDUALIZED MEDICINE; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84927961323     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1016/j.jagp.2013.05.006     Document Type: Article

References (35)

1. Centers for Disease Control and Prevention: Healthy Aging: Helping People To Live Long and Productive Lives and Enjoy a Good Quality Of Life. Atlanta, Centers for Disease Control and Prevention, 2011
2. Lebowitz BD, Pearson JL, Schneider LS, et al: Diagnosis and treatment of depression in late life. Consensus statement update. JAMA 1997; 278:1186-1190
3. US Department of Health and Human Services: Multiple Chronic Conditions-A Strategic Framework: Optimum Health and Quality of Life for Individuals with Multiple Chronic Conditions. Washington, DC, National Academies Press, 2010
4. Alexopoulos GS, Raue PJ, Sirey JA, et al: Developing an intervention for depressed, chronically medically ill elders: A model from COPD. Int J Geriatr Psychiatry 2008; 23:447-453
5. Pauwels RA, Rabe KF: Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004; 364:613-620
6. Jemal A,Ward E, Hao Y, et al: Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005; 294:1255-1259
7. ACCP/AACVPR: Pulmonary rehabilitation: Joint ACCP/AACVPR evidence-based guidelines. American College of Chest Physicians. American Association of Cardiovascular and Pulmonary Rehabilitation Pulmonary Rehabilitation Guidelines Panel. Chest 1997; 112:1363-1396
8. Borson S, Claypoole K, McDonald GJ: Depression and chronic obstructive pulmonary disease: Treatment trials. Semin Clin Neuropsychiatry 1998; 3:115-130
9. Kunik ME, Roundy K, Veazey C, et al: Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest 2005; 127:1205-1211
10. Jennings JH, Digiovine B, Obeid D, et al: The association between depressive symptoms and acute exacerbations of COPD. Lung 2009; 187:128-135
11. De Voogd JN, Wempe JB, Koeter GH, et al: Depressive symptoms as predictors of mortality in patients with COPD. Chest 2009; 135:619-625
12. Kaplan RM, Toshima M, Atkins CJ, et al: Adherence to prescribed regimens for patients with chronic obstructive pulmonary disease, in The Handbook of Health Behavior and Change. Edited by Shumaker SA, Schron EB, Ockene JK. New York, Springer Publishing Co, 1990; 126-143
13. Fritzsche A, Clamor A, von Leupoldt A: Effects of medical and psychological treatment of depression in patients with COPD- a review. Resp Med 2011; 105:1422-1433
14. Yohannes AM, Connolly MJ, Baldwin RC: A feasibility study of antidepressant drug therapy in depressed elderly patients with chronic obstructive pulmonary disease. Int J Geriatr Psychiatry 2001; 16:451-454
15. Coventry PA, Hind D: Comprehensive pulmonary rehabilitation for anxiety and depression in adults with chronic obstructive pulmonary disease: Systematic review and meta-analysis. J Psychosom Res 2007; 63:551-565
16. Cafarella PA, Effing TW, Usmani ZA, et al: Treatments for anxiety and depression in patients with chronic obstructive pulmonary disease: A literature review. Respirology 2012; 17:627-638
17. Alexopoulos GS, Kiosses DN, Sirey JA, et al: A personalized intervention for patients with depression and severe COPD. Br J Psychiatry 2013; 202:235-236
18. First MB, Spitzer RL, Williams JBW, et al: Structured Clinical Interview for DSM-IV-Patient Version (SCID-P). Washington, DC, American Psychiatric Press, 1995
19. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
20. American Thoracic Society: Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152:S77eS121
21. Folstein MF, Folstein SE, McHugh PR: "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
22. Lareau SC, Meek PM, Roos PJ: Additional testing of the modified pulmonary functional status and dyspnea questionnaire (PFSDQ-M): Ease of use, stability, reliability, and validity. Am J Crit Care Med 1997; 155:A722
23. Lareau SC, Meek PM, Roos PJ, Severe COPD: Effects on activites of daily living and dyspnea. Am J Crit Care Med 1996; 153:A421
24. Charlson ME, Pompei P, Ales KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40:373-383
25. Golden CJ: The Stroop Color and Word Test (Manual). Chicago, Stoetling, 1978
26. Mattis S: Dementia Rating Scale. Odessa, FL, Psychological Assessment Resources, 1989
27. Costa PT, McCrae RR: The NEO Personality Inventory: Manual. Odessa, FL, Psychological Assessment Resources, 1985
28. Koenig HG, Westlund RE, George LK, et al: Abbreviating the Duke Social Support Index for use in chronically ill elderly individuals. Psychosomatics 1993; 34:61-69
29. Sirey JA, Bruce ML, Kales HC: Improving antidepressant adherence and depression outcomes in primary care: The treatment initiation and participation (TIP) program. Am J Geriatr Psychiatry 2010; 18:554-562
30. Maurer J, Rebbapragada V, Borson S, et al: Anxiety and depression in COPD: Current understanding, unanswered questions, and research needs. Chest 2008; 134:43Se56S
31. Janssen DJ, Spruit MA, Leue C, et al: Symptoms of anxiety and depression in COPD patients entering pulmonary rehabilitation. Chron Respir Dis 2010; 7:147-157
32. Alexopoulos GS, Kiosses DN, Heo M, et al: Executive dysfunction and the course of geriatric depression. Biol Psychiatry 2005; 58: 204-210
33. Sneed JR, Roose SP, Keilp JG, et al: Response inhibition predicts poor antidepressant treatment response in very old depressed patients. Am J Geriatr Psychiatry 2007; 15:553-563
34. Katz PP, Gregorich S, Eisner M, et al: Disability in valued life activities among individuals with COPD and other respiratory conditions. J Cardiopulm Rehabil Prev 2010; 30:126-136
35. Hajiro T, Nishimura K, Tsukino M, et al: A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest 1999; 116:1632-1637